Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With
Hany Elmariah1, Jongphil Kim1, Rebecca Gonzalez1
1Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
American Journal of Hematology
|June 10, 2025
Abstract
No abstract available in PubMed .


